KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Gains from Investment Securities (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Gains from Investment Securities for 16 consecutive years, with -$503.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Gains from Investment Securities fell 208.59% year-over-year to -$503.0 million, compared with a TTM value of -$508.0 million through Dec 2024, up 15.89%, and an annual FY2024 reading of -$508.0 million, up 15.89% over the prior year.
  • Gains from Investment Securities was -$503.0 million for Q4 2024 at Thermo Fisher Scientific, down from $152.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $359.0 million in Q4 2022 and bottomed at -$503.0 million in Q4 2024.
  • Average Gains from Investment Securities over 5 years is -$60.4 million, with a median of -$37.0 million recorded in 2023.
  • The sharpest move saw Gains from Investment Securities skyrocketed 6500.0% in 2020, then crashed 369.52% in 2022.
  • Year by year, Gains from Investment Securities stood at $6.0 million in 2020, then soared by 3800.0% to $234.0 million in 2021, then skyrocketed by 53.42% to $359.0 million in 2022, then crashed by 145.4% to -$163.0 million in 2023, then plummeted by 208.59% to -$503.0 million in 2024.
  • Business Quant data shows Gains from Investment Securities for TMO at -$503.0 million in Q4 2024, $152.0 million in Q3 2024, and -$150.0 million in Q2 2024.